Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2885 Target Snapshot

Carbonic anhydrase 3 · SINGLE PROTEIN · Homo sapiens

443Compounds
92Assays
20Approved Drugs
612.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P07451. Use UniProt P07451 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P07451 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Carbonic anhydrase 3 as ChEMBL target CHEMBL2885, mapped to UniProt P07451. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Carbonic anhydrase 3
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL2885
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P07451
Carbonic anhydrase 3
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Carbonic anhydrase 3 is the right protein anchor across sources, using UniProt P07451 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelCarbonic anhydrase 3
UniProt AccessionP07451
Component TypeProtein
Sequence Length260 aa

Carbonic anhydrase 3

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Carbonic anhydrase 3, mapped to UniProt P07451. Sequence length is 260 aa.

Mapped IDP07451
Review nameCarbonic anhydrase 3
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

20
Approved
8
Phase III
5
Phase II
Assay Mix

Activity Type Distribution

IC503.0
KI279.0
KD330.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL19 8.96 Ki 1.1 Approved
CHEMBL20 8.51 Ki 3.1 Approved
CHEMBL4562296 8.17 Kd 6.7 Preclinical
CHEMBL4165570 8.12 Kd 7.5 Preclinical
CHEMBL4170792 8.12 Kd 7.6 Preclinical
CHEMBL120886 8.08 Kd 8.4 Preclinical
CHEMBL4161701 8.02 Kd 9.6 Preclinical
CHEMBL4442511 8.0 Kd 10.0 Preclinical
CHEMBL4578934 7.92 Kd 12.0 Preclinical
CHEMBL4437818 7.89 Kd 13.0 Preclinical
Distribution

pChEMBL Value Distribution

64
5.0
13
5.5
34
6.0
24
6.5
41
7.0
21
7.5
8
8.0
2
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

LACOSAMIDE
CHEMBL58323
Approved 2008
NILOTINIB
CHEMBL255863
Approved 2007
IMATINIB
CHEMBL941
Approved 2001
INDAPAMIDE
CHEMBL406
Approved 1983
METHAZOLAMIDE
CHEMBL19
Approved 1959
ACETAZOLAMIDE
CHEMBL20
Approved 1953
Assay Landscape

Assay Landscape

92
Total Assays
234
Tested Compounds
2
Assay Types
Binding — 90 assays, 234 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 74 144 5.2
assay format 10 90 6.0
cell-based format 6 0
ADME — 2 assays, 20 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 2 20 5.8

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine